OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies...

por Sievert, K-D, Chapple, C, Herschorn, S, Joshi, M, Zhou, J, Nardo, C, Nitti, V W
Publicado 2014

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase...

por Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Publicado 2013